BOK Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.24M Sell
16,427
-804
-5% -$386K 0.11% 153
2026
Q1
$8.47M Sell
17,231
-206
-1% -$112K 0.13% 138
2025
Q4
$10.1M Sell
17,437
-6,133
-26% -$3.47M 0.15% 124
2025
Q3
$11.4M Sell
23,570
-2,840
-11% -$1.32M 0.17% 122
2025
Q2
$10.7M Sell
26,410
-2,238
-8% -$936K 0.17% 115
2025
Q1
$14.3M Sell
28,648
-756
-3% -$409K 0.25% 80
2024
Q4
$15.9M Sell
29,404
-2,683
-8% -$1.48M 0.27% 74
2024
Q3
$19.3M Buy
32,087
+2,224
+7% +$1.32M 0.34% 57
2024
Q2
$16.5M Sell
29,863
-8,034
-21% -$4.6M 0.3% 69
2024
Q1
$21.9M Sell
37,897
-1,417
-4% -$795K 0.4% 55
2023
Q4
$20.9M Sell
39,314
-1,326
-3% -$642K 0.41% 55
2023
Q3
$18.1M Sell
40,640
-5,803
-12% -$3.09M 0.4% 57
2023
Q2
$24.2M Buy
46,443
+1,809
+4% +$976K 0.49% 47
2023
Q1
$25.7M Sell
44,634
-7,041
-14% -$3.97M 0.54% 41
2022
Q4
$28.5M Sell
51,675
-4,490
-8% -$2.38M 0.53% 41
2022
Q3
$28.5M Buy
56,165
+1,158
+2% +$648K 0.58% 37
2022
Q2
$29.9M Buy
55,007
+618
+1% +$340K 0.57% 39
2022
Q1
$32.1M Buy
54,389
+131
+0.2% +$75.3K 0.53% 40
2021
Q4
$36.2M Buy
54,258
+1,748
+3% +$1.09M 0.56% 39
2021
Q3
$30M Buy
+52,510
New +$28.8M 0.52% 42
2021
Q1
$14.8M Sell
32,403
-2,980
-8% -$1.42M 0.27% 89
2020
Q4
$16.5M Buy
35,383
+5,127
+17% +$2.4M 0.31% 74
2020
Q3
$13.4M Sell
30,256
-161
-0.5% -$66.5K 0.29% 82
2020
Q2
$11M Buy
30,417
+3,535
+13% +$1.18M 0.26% 95
2020
Q1
$7.62M Sell
26,882
-1,913
-7% -$603K 0.22% 103
2019
Q4
$9.36M Buy
28,795
+96
+0.3% +$29.1K 0.21% 115
2019
Q3
$8.36M Sell
28,699
-5,380
-16% -$1.54M 0.2% 115
2019
Q2
$10M Buy
34,079
+4,448
+15% +$1.23M 0.24% 101
2019
Q1
$8.11M Sell
29,631
-1,046
-3% -$260K 0.19% 129
2018
Q4
$6.87M Sell
30,677
-1,786
-6% -$419K 0.2% 127
2018
Q3
$7.92M Sell
32,463
-2,533
-7% -$583K 0.2% 125
2018
Q2
$7.25M Sell
34,996
-117
-0.3% -$24.8K 0.2% 127
2018
Q1
$7.25M Buy
35,113
+5,383
+18% +$1.13M 0.21% 125
2017
Q4
$5.64M Sell
29,730
-676
-2% -$130K 0.16% 154
2017
Q3
$5.75M Buy
30,406
+3,479
+13% +$630K 0.17% 144
2017
Q2
$4.7M Sell
26,927
-2,932
-10% -$492K 0.15% 158
2017
Q1
$4.59M Buy
29,859
+3,865
+15% +$591K 0.14% 165
2016
Q4
$3.67M Sell
25,994
-909
-3% -$134K 0.12% 195
2016
Q3
$4.28M Sell
26,903
-3,847
-13% -$593K 0.14% 170
2016
Q2
$4.54M Sell
30,750
-12,146
-28% -$1.79M 0.16% 142
2016
Q1
$6.07M Buy
42,896
+1,071
+3% +$144K 0.22% 106
2015
Q4
$5.93M Buy
41,825
+2,885
+7% +$385K 0.21% 112
2015
Q3
$4.76M Buy
38,940
+3,533
+10% +$460K 0.18% 136
2015
Q2
$4.59M Sell
35,407
-1,595
-4% -$208K 0.16% 151
2015
Q1
$4.97M Buy
37,002
+4,727
+15% +$609K 0.17% 141
2014
Q4
$4.04M Sell
32,275
-12,659
-28% -$1.54M 0.14% 165
2014
Q3
$5.47M Sell
44,934
-2,242
-5% -$273K 0.18% 124
2014
Q2
$5.57M Buy
47,176
+435
+0.9% +$51.2K 0.18% 130
2014
Q1
$5.62M Sell
46,741
-543
-1% -$64.6K 0.19% 126
2013
Q4
$5.26M Buy
47,284
+823
+2% +$81.8K 0.18% 129
2013
Q3
$4.28M Buy
46,461
+1,828
+4% +$165K 0.16% 145
2013
Q2
$3.78M Buy
+44,633
New +$3.72M 0.14% 151

Other funds holding TMO

BOK Financial's TMO Position: Q2 2026 in Review

BOK Financial reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2026, selling an estimated $386K and leaving 16,427 shares worth $8.24M. The position accounts for 0.11% of the portfolio, ranked #153.

BOK Financial first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.2M in Q4 2021. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BOK Financial held 16,427 shares of Thermo Fisher Scientific worth $8.24M as of Q2 2026.
  • BOK Financial sold 804 Thermo Fisher Scientific shares in Q2 2026, an estimated $386K.
  • Thermo Fisher Scientific made up 0.11% of BOK Financial's portfolio in Q2 2026, its #153 holding.
  • BOK Financial first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • BOK Financial's Thermo Fisher Scientific position peaked at $36.2M in Q4 2021.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.